Pharmaceutical

Image

Global Meningococcal Vaccines Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Dec 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Meningococcal Vaccines Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 3.07 Million
Diagram Market Size (Forecast Year) USD 5.16 Million
Diagram CAGR %

Global Meningococcal Vaccines  Market, By Type (Bivalent, Quadrivalent), Age Group (Infants, Children, Adults), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

Meningococcal Vaccines Market Analysis and Size

According to the Centers for Disease Control and Prevention (CDC) records, about 1.2 million cases of bacterial meningitis are estimated to occur globally each year. Bacterial meningitis can occur at any age. Whereas infants are at a larger risk of developing bacterial meningitis. Numerous campaigns and awareness programs are being organized by several government & non-government organizations.  

Data Bridge Market Research analyses a growth rate in the meningococcal vaccines market in the forecast period 2023-2030. The expected CAGR of the meningococcal vaccines market tends to be around 6.7% in the mentioned forecast period. The market was valued at USD 3.07 million in 2022 and would grow to USD 5.16 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Meningococcal Vaccines Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (Bivalent, Quadrivalent), Age Group (Infants, Children, Adults), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Johnson & Johnson Private Limited (U.S.), Mylan N.V. (U.S.), Sun Pharmaceutical Industries Limited (India), Sanofi S.A. (France), Merck & Co., Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), AbbVie Inc. (U.S.), Fresenius Kabi AG (Germany), Amneal Pharmaceuticals LLC. (U.S.), Pfizer Inc. (U.S.), Serum Institute of India Pvt. Ltd (India), Incepta Pharmaceuticals Ltd. (India), Walvax Biotechnology Co., Ltd (China), Bio-Manguinhos (Brazil)

Market Opportunities

  • Growing R&D Activities
  • Increasing Initiatives by Government Organizations

Market Definition

Meningococcal vaccine is typically zed as a vaccine used to prevent infection caused by Neisseria meningtidis. This vaccine is given either in the form of injection into the muscle and also under the skin. These vaccines are based on polysaccharide-based, glycoconjugate, protein-based and combined conjugate vaccines, which usually target the pathogen's serogroups. The meningococcal vaccine helps to decline the global incidence of meningococcal meningitis diseases.

Global Meningococcal Vaccines Market Dynamics

Drivers

  • Rise In The Incidence Of Meningitis

A rise in the occurrence of meningitis is anticipated to increase the demand for meningitis vaccines, therefore pushing the growth of the meningococcal vaccines market. For instance, as per the data published by Elsevier Inc., the Netherlands-based academic publishing company, in April 2021, more than 2.5 million cases and 236,000 deaths because of meningitis were reported in 2019 worldwide.

  • Increasing Awareness Programs About The Disease

Numerous campaigns and awareness programs are being organized by government & non-government organizations, such as the Meningitis Research Foundation of Canada, Meningitis B Action Project, National Meningitis Association (NMA), and others. These organizations help in promoting constant research and new approaches that are involved in disease prevention. Therefore, these factors are expected to fuel the market growth in the coming years.

Opportunities

  • Growing R&D Activities

The existence of several vaccines and research activities of phase III vaccines in the pipeline which are projected to be commercialized during the forecast period and is anticipated to fuel the market growth. For instance, in June 2020, Pfizer, Inc. initiated phase III clinical trials of PF-06886992, which is a pentavalent meningococcal vaccine candidate (MenABCWY) to evaluate & compare the safety, immunogenicity, and tolerability with licensed meningococcal vaccines in adolescents and young adults. Furthermore, Menactra, a conjugate vaccine manufactured by Serum Institute of India Pvt. Ltd. is currently in phase III clinical trial.   Thus, all these trials are boosting the growth of the market.

  • Increasing Initiatives by Government Organizations

Growing initiatives by governments of countries and other regulatory authorities are expected to boost the growth of the market during the forecast period. For instance, in September 2021, WHO and its partners launched the first-ever global strategy, Global roadmap to defeat meningitis by 2030, to fight for meningitis. The main aim is to eliminate epidemics of bacterial meningitis and decrease deaths by 70% and reduce the number of cases by 2030

 Restraints/Challenges

  • High costs will derail the market growth

The huge expenditure associated with these agents impedes the market growth. For instance, in 2018, The Johns Hopkins University researchers assessed that requiring all college students to be vaccinated against meningitis B would not be that much cost-effective. Researchers peformed a survey and found that the universal immunization against serogroup B of meningococcal disease, or meningitis B, for college-aged students would only be beneficial if the vaccine costs less than US$ 65. The average price for it is US$ 324.

This meningococcal vaccines market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the meningococcal vaccines market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Meningococcal Vaccines Market

The COVID-19 pandemic had a negative impact on the market, due to a decrease in vaccination rates for meningitis. For instance, as per the article published by Elsevier B.V., in April 2022, the number of meningococcal C conjugate vaccine doses administered from March 2019 to December 2020 was analyzed in Brazil. There were total 14,832,054 meningococcal C conjugate vaccine doses administered; 66.30% of them from March 2019 to February 2020, and 33.70%, from March 2020 to December 2020. Thus, the COVID-19 pandemic had a negative economic impact on the global meningitis vaccines market because of the decreased vaccination rates.

Recent Development

  • In April 2020, Sanofi received U.S. FDA approval for MenQuadfi. MenQuadfi is a quadrivalent meningococcal (Groups A, C, Y, W) conjugate vaccine for the prevention of invasive meningococcal disease in people aged 2 years & older.

Global Meningococcal Vaccines Market Scope

The meningococcal vaccines market is segmented on the basis of type, age group, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Bivalent
  • Quadrivalent

Age Group

  • Infants
  • Children
  • Adults

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Meningococcal Vaccines  Market Regional Analysis/Insights

The meningococcal vaccines market is analyzed and market size insights and trends are provided by type, age group, distribution channel and end-user as referenced above.

The major countries covered in the meningococcal vaccines market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing positive growth for the meningococcal vaccines market throughout the forecasted period due to the presence of key manufacturers of the product is high and, increasing research and development activities, healthcare expenditure .

North America dominates the market due to increased new research and developments on meningococcal vaccines market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Meningococcal Vaccines  Market Share Analysis

The meningococcal vaccines market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to meningococcal vaccines market.

Key players operating in the meningococcal vaccines market include:

  • Johnson & Johnson Private Limited (U.S.)
  • Mylan N.V. (U.S.)
  • Sun Pharmaceutical Industries Limited (India)
  • Sanofi S.A.(France)
  • Merck & Co., Inc. (U.S.)
  • GSK plc (U.K.)
  • Novartis AG (Switzerland)
  • AbbVie Inc. (U.S.)
  •  Fresenius Kabi AG (Germany)
  • Amneal Pharmaceuticals LLC. (U.S.)
  • Pfizer Inc. (U.S.)
  • Serum Institute of India Pvt. Ltd (India)
  • Incepta Pharmaceuticals Ltd. (India)
  • Walvax Biotechnology Co., Ltd (China)
  • Bio-Manguinhos (Brazil)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The meningococcal vaccines market was USD 3.07 million in 2022.
The meningococcal vaccines market is projected to grow at a CAGR of 6.7% during the forecast period of 2023-2030.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials